SciELO - Scientific Electronic Library Online

 
vol.89 issue7Health is more than influenzaLiving forwards, understanding backwards author indexsubject indexarticles search
Home Page  

Bulletin of the World Health Organization

Print version ISSN 0042-9686

Bull World Health Organ vol.89 n.7 Genebra Jul. 2011

http://dx.doi.org/10.2471/BLT.11.089086 

ROUND TABLE DISCUSSION

 

The classical definition of a pandemic is not elusive

 

 

Heath Kelly

Victorian Infectious Diseases Reference Laboratory, Department of Epidemiology, Locked Bag 815, Carlton South, Vic. 3053, Australia (e-mail: heath.kelly@mh.org.au)

 

 

Doshi argues cogently that the definition of pandemic influenza in 2009 was elusive but does not refer to the classical epidemiological definition of a pandemic.1 A pandemic is defined as "an epidemic occurring worldwide, or over a very wide area, crossing international boundaries and usually affecting a large number of people".2 The classical definition includes nothing about population immunity, virology or disease severity. By this definition, pandemics can be said to occur annually in each of the temperate southern and northern hemispheres, given that seasonal epidemics cross international boundaries and affect a large number of people. However, seasonal epidemics are not considered pandemics.

A true influenza pandemic occurs when almost simultaneous transmission takes place worldwide. In the case of pandemic influenza A(H1N1), widespread transmission was documented in both hemispheres between April and September 2009. Transmission occurred early in the influenza season in the temperate southern hemisphere but out of season in the northern hemisphere. This out-of-season transmission is what characterizes an influenza pandemic, as distinct from a pandemic due to another type of virus.

Simultaneous worldwide transmission of influenza is sufficient to define an influenza pandemic and is consistent with the classical definition of "an epidemic occurring worldwide". There is then ample opportunity to further describe the potential range of influenza pandemics in terms of transmissibility and disease severity. The emerging evidence for A(H1N1) is that transmissibility, as estimated by the effective reproduction number (R, or average number of people infected by a single infectious person) ranged from 1.2 to 1.3 for the general population but was around 1.5 in children (Kathryn Glass, Australian National University, personal communication). Some early estimates of R for pandemic influenza H1N1 2009 may have been overestimated.3

Severity, as estimated by the case fatality ratio, probably ranged from 0.01 to 0.03%.4–6 These values are very similar to those normally seen in the case of seasonal influenza.7,8 However, the number of deaths was higher in younger people, a recognized feature of previous influenza pandemics.9

It is tempting to surmise that the complicated pandemic definitions used by the World Health Organization (WHO) and the Centers for Disease Control and Prevention of the United States of America involved severity1,10 in a deliberate attempt to garner political attention and financial support for pandemic preparedness. As noted by Doshi, the perceived need for this support can be understood given concerns about influenza A(H5N1) and the severe acute respiratory syndrome (SARS). However, conflating spread and severity allowed the suggestion that 2009 A(H1N1) was not a pandemic. It was, in fact, a classical pandemic, only much less severe than many had anticipated or were prepared to acknowledge, even as the evidence accumulated.

In 2009 WHO declared a pandemic several weeks after the criteria for the definition of a classical pandemic had been met. Part of the delay was no doubt related to the nexus between the formal declaration of a pandemic and the manufacture of a pandemic-specific vaccine. If a classical pandemic definition had been used, linking the declaration to vaccine production would have been unnecessary. This could have been done with a severity index and, depending on the availability and quality of the emerging evidence on severity, a pandemic specific vaccine may have been deemed unnecessary. Alternatively authorities may have decided to order vaccine in much smaller quantities.

The response to A(H1N1) has been justified as being precautionary, but a precautionary response should be rational and proportionate and should have reasonable chances of success. We have argued that the population-based public health responses in Australia and, by implication, elsewhere, were not likely to succeed.11 Similarly, the authors of the draft report on the response to the International Health Regulations during the 2009 pandemic note that what happened during the pandemic reflected the activity of the virus and, by implication, not the interventions.10

Risk is assessed by anticipation of severity and precaution should be calibrated to risk. As Doshi has argued, we need to redefine pandemic influenza. We can then describe the potential severity range of future pandemics. Finally, we need to use evidence to assess severity early to anticipate risk.

Competing interests: None declared.

 

References

1. Doshi P. The elusive definition of pandemic influenza. Bull World Health Org 2011;89:532–538.         [ Links ]

2. Last JM, editor. A dictionary of epidemiology, 4th edition. New York: Oxford University Press; 2001.         [ Links ]

3. Mercer G, Glass K, Beckers N. Effective reproduction numbers are commonly overestimated early in a disease outbreak. Stat Med 2011;30:984–94.         [ Links ]

4. Donaldson LJ, Rutter PD, Ellis BM, Greaves FE, Mytton OT, Pebody RG et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 2009;339:b5213. doi:10.1136/bmj.b5213 PMID: 20007665         [ Links ]

5. Bandaranayake D, Huang QS, Bissielo A, Wood T, Mackereth G, Baker MG et al.; 2009 H1N1 Serosurvey Investigation Team. Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS ONE 2010;5:e13211. doi:10.1371/journal.pone.0013211 PMID: 20976224         [ Links ]

6. McVernon J, Laurie K, Nolan T, Owen R, Irving D, Capper H et al. Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October - December 2009. Euro Surveill 2010;15:pii=19678. PMID: 20946757         [ Links ]

7. Viboud C, Tam T, Fleming D, Handel A, Miller MA, Simonsen L. Transmissibility and mortality impact of epidemic and pandemic influenza, with emphasis on the unusually deadly 1951 epidemic. Vaccine 2006;24:6701–7. doi: 10.1016/j.vaccine.2006.05.067 PMID:16806596         [ Links ]

8. Wilson N, Baker MG. The emerging influenza pandemic: estimating the case fatality ratio. Euro Surveill 2009;14:pii=19255. PMID:19573509         [ Links ]

9. Miller MA, Viboud C, Balinska M, Simonsen L. The signature features of influenza pandemics–implications for policy. N Engl J Med 2009;360:2595– 8. doi: 10.1056/NEJMp0903906 PMID:19423872         [ Links ]

10. Report of the review committee on the functioning of the International Health Regulations (2005) and on pandemic influenza A (H1N1). International Health Regulations Review Committee; 2009. Available from: http://www.who.int/ihr/preview_report_review_committee_mar2011_en.pdf [accessed 13 April 2011]         [ Links ].

11. Kelly HA, Priest PC, Mercer GN, Dowse GK. We should not be complacent about our population-based public health response to the first influenza pandemic of the 21st century. BMC Public Health 2011;11:78. doi: 10.1186/1471-2458-11-78 PMID:21291568         [ Links ]